Overview Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects Status: Not yet recruiting Trial end date: 2022-12-11 Target enrollment: Participant gender: Summary Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical